Alto Neuroscience Inc — Quarterly Financial Statistics (NYSE:ANRO) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -13.02 M-16.56 M-13.78 M-9.92 M-11.52 M -51.77 M Cash from investing activities -506 K-24 K000 -24 K Cash from financing activities 49 K9.13 M613 K153 K50.19 M 60.08 M Free cash flow -13.53 M-16.58 M-13.78 M-9.92 M-11.52 M -51.79 M

뉴스

Top 1% Alto Neuroscience Plummets On Its Shocking Schizophrenia Miss

제퍼리스, Alto Neuroscience 목표 주가 상향 조정

Jefferies raises Alto Neuroscience stock price target on pipeline

알토 뉴로사이언스, 우울증 치료제 임상 위해 1억 2천만 달러 조달

Alto Neuroscience raises $120M to fund depression drug trial

알토 뉴로사이언스, 조현병 치료제 임상 시험 등록 완료

Alto Neuroscience completes enrollment in schizophrenia drug trial

알토 뉴로사이언스, 우울증 치료법 특허 취득

Alto Neuroscience receives patent for depression treatment method

찰단 캐피털 마켓, 알토 뉴로사이언스에 ’매수’ 등급 제시

Chardan Capital Markets assumes coverage on Alto Neuroscience stock with Buy rating

Tesla and ServiceNow among market cap stock movers on Monday